Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 930,596	$ 439,272
Trade accounts receivable, less allowance for doubtful accounts (2022 – $2,532; 2021 – $2,559)	962,215	556,922
Other accounts receivable	124,409	66,184
Inventories	1,216,213	812,920
Other current assets	116,671	132,683
Total current assets	3,350,104	2,007,981
Property, plant and equipment, at cost	8,465,403	8,074,746
Less accumulated depreciation and amortization	2,257,379	2,165,130
Net property, plant and equipment	6,208,024	5,909,616
Investments	903,861	897,708
Other assets	230,346	252,239
Goodwill	1,542,767	1,597,627
Other intangibles, net of amortization	285,303	308,947
Total assets	12,520,405	10,974,118
Current liabilities:
Accounts payable	1,091,583	647,986
Accrued expenses	330,941	763,293
Current portion of long-term debt	251,304	389,920
Dividends payable	46,097	45,469
Income taxes payable	61,837	27,667
Total current liabilities	1,781,762	1,874,335
Long-term debt	3,205,730	2,004,319
Postretirement benefits	43,079	43,693
Pension benefits	205,890	229,187
Other noncurrent liabilities	591,021	663,698
Deferred income taxes	391,948	353,279
Commitments and contingencies (Note 10)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 117,122 in 2022 and 117,015 in 2021	1,171	1,170
Additional paid-in capital	2,927,086	2,920,007
Accumulated other comprehensive loss	(507,138)	(392,450)
Retained earnings	3,664,172	3,096,539
Total Albemarle Corporation shareholders’ equity	6,085,291	5,625,266
Noncontrolling interests	215,684	180,341
Total equity	6,300,975	5,805,607
Total liabilities and equity	$ 12,520,405	$ 10,974,118